GOLD and the fixed ratio

European Respiratory Journal

Volumn 38, Issue 2, 2011, Pages 482-484

  Quanjer, P H ^a   Enright, P L ^c   Ruppel, G ^d   Miller, M R ^g   Vaz Fragoso, C A ^e   Cooper, B G ^h   Swanney, M P ^j   Stanojevic, S ⁱ   Jensen, R L ^f   Schouten, J P ^b   Falaschetti, E ⁱ   Stocks, J ⁱ  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY OF ARIZONA   (United States)

^d SAINT LOUIS UNIVERSITY HOSPITAL   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f LDS HOSPITAL   (United States)

^g QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^h UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

ⁱ UNIVERSITY COLLEGE LONDON   (United Kingdom)

^j CHRISTCHURCH HOSPITAL   (New Zealand)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT;

CHRONIC OBSTRUCTIVE LUNG DISEASE; COUGHING; DEVELOPING COUNTRY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DYSPNEA; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LETTER; PRACTICE GUIDELINE; PRIORITY JOURNAL; REFERENCE VALUE; SMOKING; SPIROMETRY;

EID: 80051505622     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00063211     Document Type: Letter

References (10)

1. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for Diagnosis, Management, and Prevention of COPD. Updated 2010. www.goldcopd.com Date last accessed:March 18, 2011.
2. Geijer RM, Sachs AP, Verheij TJ, et al. Incidence and determinants of moderate COPD (GOLD II) in male smokers aged 40-65 years: 5-year follow up. Br J Gen Pract 2006; 56: 656-661. (Pubitemid 44390237)
3. Qaseem A, Snow V, Shekelle P, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2007; 147: 633-638. (Pubitemid 351664484)
4. Enright P, Brusasco V. Counterpoint: Should we abandon FEV1/ FVC <0.70 to detect airway obstruction? Yes. Chest 2010; 138: 1040-1042.
5. Mannino DM, Buist AS, Vollmer WM. Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function? Thorax 2007; 62: 237-241. (Pubitemid 46579804)
6. Vaz Fragoso CA, Concato J, McAvay G, et al. The ratio of forced expiratory volume in 1-second to forced vital capacity as a basis for establishing chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010; 181: 446-451.
7. Vaz Fragoso C, Gill T, McAvay G, et al. Evaluating respiratory impairment in middle-aged persons using lambda-mu-sigma derived z-scores. Respir Care 2011; (In press).
8. Bridevaux PO, Gerbase MW, Probst-Hensch NM, et al. Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD. Thorax 2008; 63: 768-774.
9. Vollmer WM, Gíslason B, Burney P, et al. Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study. Eur Respir J 2009; 34: 588-597.
10. Miller MR, Quanjer PH, Swanney MO, et al. Interpreting lung function data using 80% predicted and fixed thresholds mis-classifies more than 20% of patients. Chest 2011; 139: 52-59.